Betapace: Effective Rhythm Control for Atrial and Ventricular Arrhythmias - Evidence-Based Review

Product Description Betapace, known generically as sotalol hydrochloride, is a class III antiarrhythmic agent with additional beta-adrenergic blocking (class II) properties. It is not a dietary supplement or a medical device, but a prescription medication approved for the treatment of documented, life-threatening ventricular arrhythmias and for the maintenance of normal sinus rhythm in patients with symptomatic atrial fibrillation or atrial flutter. It exists in both non-β-blocking (racemic) and β-blocking forms, with its antiarrhythmic efficacy primarily attributed to its potassium channel blockade, which prolongs the cardiac action potential duration and refractory period.